Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.03% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TGTX · Jun 30, 2025
TG THERAPEUTICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-25-025745General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.27% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
92.13% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
109.96% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
86.58% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
24.69% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.52% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
11.62% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20235/7 normalizedLevel 3Sep 30, 20235/8 normalizedLevel 3Dec 31, 20235/9 normalizedLevel 3Mar 31, 20244/7 normalizedLevel 3Jun 30, 20245/7 normalizedLevel 3Sep 30, 20245/7 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.02%
- Current
- 0.03%
- Delta
- 0.01%
- Previous
- -23.76%
- Current
- 5.27%
- Delta
- 29.03%
- Previous
- 90.40%
- Current
- 92.13%
- Delta
- 1.72%
- Previous
- 130.53%
- Current
- 109.96%
- Delta
- -20.58%
- Previous
- 87.14%
- Current
- 86.58%
- Delta
- -0.56%
- Previous
- 7.13%
- Current
- 24.69%
- Delta
- 17.55%
- Previous
- 38.36%
- Current
- 22.52%
- Delta
- -15.84%
- Previous
- 12.39%
- Current
- 11.62%
- Delta
- -0.77%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TGTX Fundamental State →Analogous To · TGTX state analogue 3 →Has State · TG THERAPEUTICS, INC. →Transitioned To · TGTX Fundamental State →Transitioned To · TGTX CAPEX_INTENSITY_INCREASED →Transitioned To · TGTX CASH_GENERATION_INCREASED →Transitioned To · TGTX GROWTH_INCREASED →Transitioned To · TGTX INVENTORY_PRESSURE_DECREASED →Transitioned To · TGTX MARGIN_DECREASED →Transitioned To · TGTX PROFITABILITY_INCREASED →Transitioned To · TGTX R_AND_D_INTENSITY_DECREASED →Transitioned To · TGTX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.